Patient education
- This module talks about chemoradiation treatment, how it works, and the treatment side effects.
- Chemoradiation Learning Module (text version) »
Things to remember after chemoradiation for your brain tumour is over:
- This video is for CNS (brain tumour) patients who are taking both chemotherapy and radiation for brain tumours. There can be a lot of questions around what to do after treatment has finished. We hope that this video will answer some of the questions you might have.
What types of tumours do we treat within the central nervous system cancer care group?
- Malignant (high grade) primary brain tumours including:
- Glioblastoma multiforme
- Anaplastic glioma (oligodendroglioma, astrocytoma, mixed)
- Medulloblastoma
- Malignant meningioma
- Malignant secondary or metastatic brain tumours
- Low grade primary brain tumours:
- Low grade glioma (astrocytoma, oligodedroglioma, mixed)
- Low grade glioma (astrocytoma, oligodedroglioma, mixed)
- Benign brain tumours:
- Benign meningioma
- Acoustic neuroma
- Pituitary adenom
- Spine tumours:
- Spine metastases
- Spine ependymoma
- Spine glioma
Are there any new techniques?
Yes, recent advances in the field of Central Nervous System Tumour management include new radiation techniques for certain tumours. For a particular type of malignant primary brain tumour called glioblastoma multiforme or "GBM", some patients are now being treated with both radiation and chemotherapy.
For specific situations/tumours, unique services such as high technology radiation therapy are available. These services include:
- Intensity modulated radiation therapy
- Tomotherapy
- Stereotactic radiosurgery
- Stereotactic radiation therapy
Want to learn more about your cancer?
Annual Crolla Day Lectureship
The Crolla Brain Tumour Research Unit at Sunnybrook Hospital, chaired by Dr. James Perry, has been successful in enabling enhancements in clinical care. The generous Crolla family donation has been instrumental in enabling research initiatives, which hopefully will improve the duration and quality of life in our central nervous system patients.
This lecture, usually held every October during Brain Tumour Awareness Month, is available to patients, their caregivers and health professionals.
